Studies on human papillomavirus (HPV) 16 E2, E5 and E7 mRNA in HPV-positive tonsillar and base of tongue cancer in relation to clinical outcome and immunological parameters

Highlights • Most HPV 16 DNA positive TSCC and BOTSCC biopsies expressed HPV16 E7 mRNA. • Of HPV16 DNA E7 mRNA positive TSCC and BOTSCC, 65% also expressed E2 and E5 mRNA. • HPV16 DNA positive/E2 mRNA negative TSCC and BOTSCC had worse prognosis. • HPV16 E2, E5 and E7 mRNA expression was not correla...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oral oncology 2015-12, Vol.51 (12), p.1126-1131
Hauptverfasser: Ramqvist, Torbjörn, Mints, Michael, Tertipis, Nikolaos, Näsman, Anders, Romanitan, Mircea, Dalianis, Tina
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Highlights • Most HPV 16 DNA positive TSCC and BOTSCC biopsies expressed HPV16 E7 mRNA. • Of HPV16 DNA E7 mRNA positive TSCC and BOTSCC, 65% also expressed E2 and E5 mRNA. • HPV16 DNA positive/E2 mRNA negative TSCC and BOTSCC had worse prognosis. • HPV16 E2, E5 and E7 mRNA expression was not correlated to HLA class I expression. • HPV16 E2, E5 and E7 mRNA expression was not correlated to CD8+ TIL counts.
ISSN:1368-8375
1879-0593
1879-0593
DOI:10.1016/j.oraloncology.2015.09.007